• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Salesforce's Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

    12/17/25 9:00:00 AM ET
    $CRM
    $NVS
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CRM alert in real time by email

    Salesforce (NYSE:CRM), the world's #1 AI CRM, announced today that Novartis (NYSE:NVS), a leading global innovative medicines company, has selected Salesforce's Agentforce Life Sciences for Customer Engagement to connect patient and healthcare professional (HCP) experiences, enabling teams to focus on strategic and meaningful customer interactions. Building upon its existing investments with Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft for Life Sciences and Agentforce Marketing, Novartis plans to unify engagement across marketing, sales, patient services, medical, market access, and other service stakeholders to drive more cohesive, intelligent healthcare touchpoints.

    Novartis plans to roll out Salesforce's Agentforce 360 for Life Sciences platform globally over the next five years, with the goal of radically simplifying orchestration and experiences across its teams. The platform will allow them to become more integrated around the customer, with compliance capabilities and customer insights embedded directly through AI and data harmonization.

    "The expanded partnership with Novartis underscores our commitment to transforming how the life sciences industry engages with marketing, sales, and medical stakeholders," said Frank Defesche, General Manager of Life Sciences at Salesforce. "By unifying engagement on Agentforce Life Sciences, we're providing the foundation for more personal, accurate, and connected experiences. This collaboration is ultimately about getting the right therapies to the patients that need them."

    Learn more:

    • Discover how Salesforce is leading the next era of life sciences transformation
    • Hear from some of the 70+ organizations who selected Agentforce Life Sciences
    • Get a sneak peek of the Regulated Content roadmap and transition framework
    • Read about Salesforce's robust partner network, including Deloitte Digital, Honeywell, and ZS

    About Salesforce

    Salesforce helps organizations of any size become agentic enterprises — integrating humans, agents, apps, and data on a trusted, unified platform to unlock unprecedented growth and innovation. Visit www.salesforce.com for more information.

    Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251217141127/en/

    Maha Neouchy

    Salesforce

    Public Relations

    408-568-8442

    [email protected]

    Get the next $CRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRM
    $NVS

    CompanyDatePrice TargetRatingAnalyst
    Salesforce Inc.
    $CRM
    2/26/2026$235.00 → $225.00Outperform
    BMO Capital Markets
    Salesforce Inc.
    $CRM
    2/20/2026$275.00 → $235.00Outperform
    BMO Capital Markets
    Novartis AG
    $NVS
    1/27/2026Buy
    Citigroup
    Salesforce Inc.
    $CRM
    1/12/2026$330.00Buy
    Goldman
    Novartis AG
    $NVS
    1/6/2026Underweight → Equal Weight
    Barclays
    Novartis AG
    $NVS
    12/8/2025Neutral → Overweight
    Analyst
    Salesforce Inc.
    $CRM
    12/4/2025$280.00 → $275.00Outperform
    BMO Capital Markets
    Novartis AG
    $NVS
    12/3/2025Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $CRM
    $NVS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 1, 2024 - FDA Roundup: November 1, 2024

    For Immediate Release: November 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub,” by Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER) and Peter Marks, M.D., Ph.D., director

    11/1/24 3:18:19 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CRM
    $NVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Alber Laura converted options into 442 shares, increasing direct ownership by 7% to 6,959 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    2/23/26 8:04:52 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Director Chang Amy converted options into 442 shares, increasing direct ownership by 52% to 1,290 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    2/23/26 8:03:26 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Director Conway Craig converted options into 442 shares, increasing direct ownership by 5% to 9,054 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    2/23/26 8:01:29 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    $CRM
    $NVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Formula 1 and Salesforce Deepen Partnership, Expanding Agentforce to Grow Fan Connection Worldwide

    AI-powered fan companion agent surfaces insights on F1's new 2026 technical regulations Salesforce (NYSE:CRM), the world's #1 AI CRM, and Formula 1 (NASDAQ:FWONA, FWONK, LLYVA, LLYVK)), the world's most popular annual sporting series, today announced the launch of a new fan companion agent to scale and personalize engagement for F1's 827 million global fans. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303743004/en/ Developed as part of the multi-year partnership extension between Salesforce and Formula 1, the new agent will initially be available on F1.com and act as a vital tool to provide fans with 24/7 education on th

    3/3/26 8:00:00 AM ET
    $CRM
    $FWONA
    Computer Software: Prepackaged Software
    Technology
    Broadcasting
    Industrials

    Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

    Adds Avidity's differentiated muscle-directed Antibody Oligonucleotide Conjugates (AOC) platform and three late-stage programs to industry-leading neuromuscular pipelinePotentially unlocks multi-billion-dollar opportunities with planned product launches before 2030Strengthens late-stage pipeline to further support 2025-2030 net sales CAGR of 5-6% cc and mid to long term growth outlook Basel, February 27, 2026 -- Novartis AG (NYSE:NVS) today announced that it has successfully completed its acquisition of Avidity Biosciences, Inc. ("Avidity"). With the completion of the acquisition, Avidity is now an indirect, wholly owned subsidiary of Novartis. "Avidity's breakthrough science combined with

    2/27/26 9:00:00 AM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Salesforce Targets the ITSM Status Quo: 180 Organizations Replace Legacy Support Tools with Agentforce IT Service

    Salesforce (NYSE:CRM), the world's #1 CRM, today announced more than 180 organizations have selected Agentforce IT Service, which has transformed the IT Service Management (ITSM) landscape in just four months after launching into general availability. In an industry long stifled by costly and complex ITSM systems, Agentforce IT Service has emerged as the only complete agentic AI solution, delivering a unified, Slack-first, Microsoft Teams-ready platform where humans and autonomous agents work collaboratively. By leveraging over 20 years of market leadership with Service Cloud (now Agentforce Service), Salesforce is transforming the $50 billion ITSM market and disrupting the industry incum

    2/26/26 8:00:00 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    $CRM
    $NVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk David Blair bought $500,722 worth of shares (1,936 units at $258.64), increasing direct ownership by 22% to 10,677 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    12/18/25 5:10:12 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Director Morfit G Mason bought $25,015,680 worth of shares (96,000 units at $260.58) (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    12/8/25 9:30:14 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Director Kirk David Blair bought $865,827 worth of shares (3,400 units at $254.66), gifted 4,278 shares and received a gift of 4,278 shares, increasing direct ownership by 1,811% to 8,102 units (SEC Form 4)

    4 - Salesforce, Inc. (0001108524) (Issuer)

    9/10/25 7:45:16 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    $CRM
    $NVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Salesforce with a new price target

    BMO Capital Markets reiterated coverage of Salesforce with a rating of Outperform and set a new price target of $225.00 from $235.00 previously

    2/26/26 6:51:04 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Salesforce with a new price target

    BMO Capital Markets reiterated coverage of Salesforce with a rating of Outperform and set a new price target of $235.00 from $275.00 previously

    2/20/26 7:54:01 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Citigroup initiated coverage on Novartis AG

    Citigroup initiated coverage of Novartis AG with a rating of Buy

    1/27/26 8:47:55 AM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CRM
    $NVS
    SEC Filings

    View All

    SEC Form 10-K filed by Salesforce Inc.

    10-K - Salesforce, Inc. (0001108524) (Filer)

    3/2/26 4:24:59 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Salesforce Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Salesforce, Inc. (0001108524) (Filer)

    2/25/26 4:03:12 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    SEC Form S-8 filed by Novartis AG

    S-8 - NOVARTIS AG (0001114448) (Filer)

    2/4/26 4:30:35 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CRM
    $NVS
    Leadership Updates

    Live Leadership Updates

    View All

    Salesforce Appoints Amy Chang and David B. Kirk to its Board of Directors

    New directors deepen the Board's innovation leadership and technical expertise for the agentic AI era Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced the appointments of Amy Chang, accomplished technology executive, AI entrepreneur, and advisor, and David Kirk, pioneering computer scientist and former NVIDIA chief scientist, to the Salesforce Board of Directors, effective immediately. "I'm thrilled to welcome Amy and David to Salesforce's Board. Their exceptional experience driving innovation and deep technical expertise will be invaluable as we unlock the full potential of human-AI collaboration and digital labor for our customers with Agentforce and across our deeply uni

    7/9/25 9:00:00 AM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    GeminiBio Appoints Mike Stella to Board

    Strengthening Board with Industry Veterans Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based healthcare private equity firm, announced today the appointment of Michael Stella to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218608576/en/Mike Stella, CEO of Ascend Advanced Therapies, joins the Board at GeminiBio to provide strategic leadership in the fields of cell and gene therapy contract development and manufacturing. (Photo: Business Wire) GeminiBio prov

    2/18/25 9:00:00 AM ET
    $AMGN
    $GSK
    $JNJ
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Salesforce Appoints Robin Washington as President and Chief Operating and Financial Officer

    Brian Millham, President and COO, to Retire After 25 Years at Salesforce Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that Robin Washington will become President and Chief Operating and Financial Officer (COFO), effective March 21, 2025. In this newly created role, Washington will lead Salesforce's next phase of transformation—driving profitable growth, operational excellence, and financial strategy—while accelerating the transformation of every company into an Agentforce company, in the new agentic era. A seasoned executive and visionary leader, Washington has spent decades at the forefront of financial and operational strategy at some of the world's most respected com

    2/5/25 4:05:00 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    $CRM
    $NVS
    Financials

    Live finance-specific insights

    View All

    Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

    Adds Avidity's differentiated muscle-directed Antibody Oligonucleotide Conjugates (AOC) platform and three late-stage programs to industry-leading neuromuscular pipelinePotentially unlocks multi-billion-dollar opportunities with planned product launches before 2030Strengthens late-stage pipeline to further support 2025-2030 net sales CAGR of 5-6% cc and mid to long term growth outlook Basel, February 27, 2026 -- Novartis AG (NYSE:NVS) today announced that it has successfully completed its acquisition of Avidity Biosciences, Inc. ("Avidity"). With the completion of the acquisition, Avidity is now an indirect, wholly owned subsidiary of Novartis. "Avidity's breakthrough science combined with

    2/27/26 9:00:00 AM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Salesforce Announces Timing of its Fourth Quarter and Full Year Fiscal 2026 Results Conference Call

    Results to be released on February 25, 2026, after market close Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that its fourth quarter and full year fiscal 2026 results will be released on Wednesday, February 25, 2026, after the close of the market. The company will host a conference call at 2:00 p.m. (PT) / 5:00 p.m. (ET) to discuss its financial results with the investment community. A live webcast and replay of the event will be available on the Salesforce Investor Relations website at www.salesforce.com/investor. About Salesforce Salesforce helps organizations of any size become agentic enterprises — integrating humans, agents, apps, and data on a trusted, unified p

    2/4/26 4:30:00 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Salesforce Announces Quarterly Dividend

    Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that its board of directors declared a quarterly cash dividend of $0.416 per share. The dividend is payable January 8, 2026 to shareholders of record on December 18, 2025. About Salesforce Salesforce helps organizations of any size become agentic enterprises — integrating humans, agents, apps, and data on a trusted, unified platform to unlock unprecedented growth and innovation. Visit www.salesforce.com for more information. View source version on businesswire.com: https://www.businesswire.com/news/home/20251204068615/en/ Mike Spencer Salesforce Investor Relations [email protected] Carolyn Guss Salesforce Public Relation

    12/4/25 8:49:00 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    $CRM
    $NVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Salesforce Inc.

    SC 13G/A - Salesforce, Inc. (0001108524) (Subject)

    11/14/24 1:22:34 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Novartis AG

    SC 13D/A - NOVARTIS AG (0001114448) (Filed by)

    10/17/24 4:01:28 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Salesforce Inc.

    SC 13G - Salesforce, Inc. (0001108524) (Subject)

    10/16/24 12:53:21 PM ET
    $CRM
    Computer Software: Prepackaged Software
    Technology